Eventide Asset Management - NURIX THERAPEUTICS INC ownership

NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 119 filers reported holding NURIX THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Eventide Asset Management ownership history of NURIX THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$14,621,000
-44.2%
1,154,000
-38.3%
0.31%
-23.7%
Q1 2022$26,199,000
-51.6%
1,870,0000.0%0.41%
-40.8%
Q4 2021$54,137,000
+50.6%
1,870,000
+55.8%
0.69%
+46.0%
Q3 2021$35,952,000
+12.9%
1,200,0000.0%0.47%
+10.7%
Q2 2021$31,836,000
-14.7%
1,200,0000.0%0.43%
-22.6%
Q1 2021$37,308,000
+8.1%
1,200,000
+14.3%
0.55%
+4.5%
Q4 2020$34,524,000
+98.7%
1,050,000
+111.0%
0.53%
+55.6%
Q3 2020$17,376,000497,7400.34%
Other shareholders
NURIX THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 1,822,883$14,327,8601.60%
DAFNA Capital Management LLC 556,695$4,375,6231.36%
Redmile Group, LLC 2,848,827$22,391,7801.06%
Deep Track Capital, LP 2,997,830$23,562,9440.91%
WestHill Financial Advisors, Inc. 283,333$2,226,9970.65%
Soleus Capital Management, L.P. 814,000$6,398,0400.59%
Affinity Asset Advisors, LLC 250,000$1,965,0000.55%
Boxer Capital, LLC 1,224,892$9,627,6510.51%
AtonRa Partners 24,227$190,4240.40%
WASATCH ADVISORS LP 3,564,616$28,017,8820.18%
View complete list of NURIX THERAPEUTICS INC shareholders